Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL

Clinical trial NCT04697940 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04697940
Sponsor: Han weidong
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma Decitabine-primed Tandem CD19/CD20 CAR T Cells

Start date: 2021-04-15
Primary completion: 2025-05-31
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.